The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
23 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,103,419 in first-year total cost, median $134,861.
Most frequent study sections
- Clinical Research and Field Studies of Infectious Diseases Study Section[CRFS]7
- Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section[DDR]3
- Pathogenic Eukaryotes Study Section[PTHE]3
- Etiology, Diagnostic, Intervention and Treatment of Infectious Diseases Study Section[EDIT]2
- Vector Biology Study Section[VB]2
Most frequent institutions
- NATIONAL RESEARCH COUNCIL OF ARGENTINA3
- UNIV OF SCIENCES, TECH & TECH OF BAMAKO2
- UNIVERSITY OF GHANA2
- --INSTITUTE OF MARINE BIOCHEMISTRY1
- BIOTECHNOLOGY RESEARCH INSTITUTE-KALRO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Cellular and molecular architecture of granulomas in human tuberculous lymphadenitis1R01AI169526-01A1 | BENABDESSALEM, CHAOUKI | INSTITUT PASTEUR DE TUNIS | $147,240 | HIBP |
| 2023 | Gastroenteritis virus infections in South African children: secretor status-linkedsusceptibility, prevalence and genetic diversity and humoral responses to norovirusinfection1R01AI176494-01 | MANS, JANET | UNIVERSITY OF PRETORIA | $137,000 | EDIT |
| 2023 | Ecology and genetics of insecticide resistance in African malaria vectors2R01AI123074-06A1 | AFRANE, YAW ASARE | UNIVERSITY OF GHANA | $137,000 | VB |
| 2023 | A new method for active tuberculosis case finding1R01AI176581-01 | AMOUR, MARYAM | MUHIMBILI UNIVERSITY/ ALLIED HLTH SCIS | $134,946 | PRID |
| 2023 | Targeting purinergic signaling in Chagas disease1R01AI176457-01 | AOKI, MARIA PILAR | NATIONAL RESEARCH COUNCIL OF ARGENTINA | $130,742 | PTHE |
| 2023 | Genomics and sero-epidemiology of Plasmodium falciparum malaria in a pre-elimination setting1R01AI176569-01 | SAENZ, FABIAN ERNESTO | PONTIFICIA UNIVERSIDAD CATOLICA DEL ECUADOR | $129,440 | EDIT |
| 2023 | Mechanisms underlying diarrhea and gut inflammation mediated by Enterotoxigenic and Enteropathogenic E. coli1R01AI169618-01A1 | VISWESWARIAH, SANDHYA | INDIAN INSTITUTE OF SCIENCE | $121,630 | DNPD |
| 2022 | Expanding the toolbox for tsetse control in Kenya1R01AI169503-01 | MIREJI, PAUL O | BIOTECHNOLOGY RESEARCH INSTITUTE-KALRO | $146,576 | VB |
| 2022 | Impact of SARS-CoV-2 infection on reactivation of latent Mtb infections in a Kenyan Cohort1R01AI169534-01 | GITAKA, JESSE | MOUNT KENYA UNIVERSITY | $140,534 | CRFS |
| 2022 | Invasive Pneumococcal Disease and Carriage among Children with Sickle Cell Disease in Ghana: A Post-vaccination Study1R01AI169674-01 | SAMPANE-DONKOR, ERIC | UNIVERSITY OF GHANA | $134,924 | CRFS |
| 2022 | DNA methylation, 3D genome organization and gene expression during Trichomonas vaginalis: host interaction1R01AI160387-01A1 | DE MIGUEL, NATALIASTROBL MAZZULLA, PABLO HERNAN | INSTITUTE/RESEARCH/BIOTECHNOLOGY FDN | $133,720 | PTHE |
| 2022 | Immunoregulation of cellular immunity and tissue homeostasis during Chagas' disease1R01AI169482-01 | ACOSTA RODRIGUEZ, EVA V | NATIONAL RESEARCH COUNCIL OF ARGENTINA | $133,400 | IHD |
| 2022 | "Investigating the rebound effects of seasonal malaria chemoprevention (SMC) in Mali"1R01AI169517-01 | TOURE, MAHAMOUDOU | UNIV OF SCIENCES, TECH & TECH OF BAMAKO | $133,320 | CRFS |
| 2022 | Antibody-secreting Cells in the Outcome of Trypanosoma cruzi Infection2R01AI116432-06A1 | GRUPPI, ADRIANA | NATIONAL RESEARCH COUNCIL OF ARGENTINA | $133,000 | PTHE |
| 2022 | Characterizing novel Beta-lactamases from metagenomic samples: insights into the evolution of antimicrobial resistance from the environment towards human-associated pathogens1R01AI160371-01A1 | POWER, PABLO | UBATEC S.A. | $127,728 | DDR |
| 2021 | Characterisation of drug resistance in field-collected schistosomes1R01AI160433-01 | NDOMBI, ERIC MAKUTO | KENYATTA UNIVERSITY | $159,500 | DDR |
| 2021 | Clinical Predictors of weekly Rifapentine/isoniazid related adverse drug reactions during national roll-out of tuberculosis preventive therapy1R01AI160434-01 | SEKAGGYA-WILTSHIRE, CHRISTINE | INFECTIOUS DISEASES INSTITUTE | $138,370 | CRFS |
| 2021 | Emerging zoonotic malaria in Malaysia: strengthening surveillance and evaluating population genetic structure to improve regional risk prediction tools1R01AI160457-01 | RAJAHRAM, GIRI | INFECTIOUS DISEASE SOCIETY KOTA KINABALU | $135,502 | CRFS |
| 2021 | The age-specific impact of seasonal malaria chemoprevention on malaria incidence, antibody responses, and parasite reservoirs in Malian children1R01AI150534-01A1 | COULIBALY, DRISSA | UNIV OF SCIENCES, TECH & TECH OF BAMAKO | $135,000 | CRFS |
| 2021 | Validation of Trypanosoma cruzi dihydroorotate dehydrogenase as a drug target for Chagas´disease.1R01AI160379-01 | EMERY, FLAVIO DA SILVANONATO, MARIA CRISTINA | UNIVERSITY OF SAO PAULO | $134,861 | DDR |
| 2021 | Identification of antimicrobial reagents against TB and ESKAPE pathogens from bacteria collected in Vietnam1R01AI160696-01 | NGUYEN, LINH THUYTRAN, TUAN ANH | --INSTITUTE OF MARINE BIOCHEMISTRY | $129,670 | ZRG1 |
| 2021 | Mechanisms of type I IFN signaling and HIV risk in the female genital tract1R01AI162001-01 | SIVRO, AIDA | CENTRE/AIDS PROGRAMME/RES/SOUTH AFRICA | $128,760 | HIVD |
| 2021 | Targeting non-coding RNAs as host-directed drug therapy for tuberculosis1R01AI160501-01 | GULER, RETOHIDE, WINSTON ALEXANDER | UNIVERSITY OF CAPE TOWN | $120,556 | CRFS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.